Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Cryo-Cell International, Inc. before investing.

In this article, we go over a few key elements for understanding Cryo-Cell International, Inc.’s stock price such as:

• Cryo-Cell International, Inc.’s current stock price and volume
• Why Cryo-Cell International, Inc.’s stock price changed recently
• Upgrades and downgrades for CCEL from analysts
• CCEL’s stock price momentum as measured by its relative strength

About Cryo-Cell International, Inc. (CCEL)

Before we jump into Cryo-Cell International, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer’s disease, Parkinson’s diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Want to learn more about Cryo-Cell International, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Cryo-Cell International, Inc..

What Caused Cryo-Cell International, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of February 28, 2025,, no analysts have changed their rating of Cryo-Cell International, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Cryo-Cell International, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Cryo-Cell International, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Cryo-Cell International, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Cryo-Cell International, Inc. (CCEL) by visiting AAII Stock Evaluator.

Relative Price Strength of Cryo-Cell International, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 28, 2025, Cryo-Cell International, Inc. has a weighted four-quarter relative price strength of 8.68%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how Cryo-Cell International, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Cryo-Cell International, Inc. Stock Price: Bottom Line

As of March 3, 2025, Cryo-Cell International, Inc.’s stock price is $6.720, which is down 14.94% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Cryo-Cell International, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.